pH, pKa, and the Titration Curve of a Basic Amino Acid

1. Relationship Between pH and pKa

• pKa is a constant property of a given ionizable group - it is the pH at which exactly 50% of that group's molecules are protonated and 50% are deprotonated (i.e., [A⁻] = [HA], so log(1) = 0 and pH = pKa).
• pH is a variable describing the actual hydrogen ion concentration of a solution at any given moment; it changes as acid or base is added.
• When pH < pKa, the protonated form (HA) predominates; when pH > pKa, the deprotonated form (A⁻) predominates.
• A weak acid or weak base shows its greatest buffering capacity within about ±1 pH unit of its pKa, because in this range small additions of acid/base produce the smallest change in pH (the titration curve is flattest here) - Harper's Illustrated Biochemistry, p. 605.
• Far from the pKa (>1-2 pH units away), the solution has little buffering capacity and pH changes rapidly with added acid or base.

2. Titration Curve of a Basic Amino Acid

Using lysine as the example (α-COOH, α-NH3⁺, ε-NH3⁺ side chain):

1. pH < pKa1 (≈2.2): All three groups are protonated (-COOH, α-NH3⁺, ε-NH3⁺) → net charge +2.
2. pKa1 to pKa2 (2.2-9.0): The α-carboxyl loses its proton (-COO⁻), while both amino groups remain protonated → net charge +1. This is the first buffering region and the plateau around pKa1 is the first buffering zone.
3. pKa2 to pKa3 (9.0-10.5): The α-amino group loses its proton (-NH2), the ε-amino group is still protonated → net charge 0. This is where the isoelectric point (pI) falls.
4. pH > pKa3 (>10.5): Both amino groups are deprotonated → net charge -1.

3. Isoelectric Focusing (IEF)

Importance in 2D Gel Electrophoresis

1. First dimension - IEF: Proteins are separated according to their pI (net charge/amino acid composition), moving along a pH gradient.
2. Second dimension - SDS-PAGE: The IEF strip is then placed on top of an SDS-polyacrylamide gel and run at right angles to the first dimension, separating the same proteins by molecular mass.

• High resolving power: 2D-IEF/SDS-PAGE can resolve hundreds to thousands of individual protein spots from a single complex sample (e.g., whole-cell lysate, serum, CSF), far more than either technique alone - Henry's Clinical Diagnosis and Management by Laboratory Methods.
• Proteomics and biomarker discovery: it is a cornerstone method for comparing protein expression profiles between normal and diseased tissue (e.g., identifying isoform shifts, post-translational modifications that alter charge, or disease-specific protein spots) - Rheumatology, 2-Volume Set, p. 1670-1686.
• Detecting charge-based isoforms: proteins with identical molecular weight but different post-translational modifications (phosphorylation, glycosylation) that shift pI - such as MHC class II molecule isoforms - can be distinguished as multiple spots at the same horizontal (mass) level but different vertical (pI) positions - Janeway's Immunobiology, p. 832.
• Clinical laboratory use: IEF combined with a second-dimension separation is used clinically, for example, in CSF protein analysis (oligoclonal band detection) and characterization of complex protein mixtures such as pancreatic exocrine proteins - Henry's Clinical Diagnosis and Management by Laboratory Methods.

Simple Explanation

1. pH and pKa - What's the Relationship?

• pH = how acidic or basic the solution actually is right now (it changes).
• pKa = a fixed number for a particular group, telling you the pH at which that group is exactly half-ionized.

• If pH is lower than pKa → the group stays protonated (holds onto its H⁺, carries its "acid" form).
• If pH is higher than pKa → the group loses its H⁺ (becomes its "base" form).
• If pH = pKa → exactly half the molecules have the proton, half don't.

2. Titration Curve of a Basic Amino Acid (example: Lysine)

1. α-COOH group → pKa1 ≈ 2.2
2. α-NH3⁺ group → pKa2 ≈ 9.0
3. side-chain NH3⁺ group (extra amino group) → pKa3 ≈ 10.5

3. Isoelectric Focusing (IEF) - Simple Explanation

• If it drifts a little too far in one direction, it picks up a charge again and gets pulled back to its correct spot. This makes IEF very precise - it can separate proteins whose pI differs by only 0.01 units.

Why IEF Matters in 2D Gel Electrophoresis

1. Step 1 (IEF): separate proteins left-to-right by their pI (charge).
2. Step 2 (SDS-PAGE): turn the gel 90 degrees and separate the same proteins top-to-bottom by their size.

• It can distinguish hundreds to thousands of proteins from one sample, way more than either method alone.
• It can tell apart two proteins of the same size but different charge (for example, the same protein with or without a phosphate group attached, which changes its charge but not its size).
• It's widely used to compare healthy vs. diseased tissue samples, spot disease markers, and study complex protein mixtures like spinal fluid or blood serum.

De Novo Purine Ring Synthesis, Its Regulation, and ADA Deficiency-Related SCID

1. Biochemical Steps in De Novo Purine Ring Synthesis

• Glycine - contributes carbons 4, 5 and nitrogen 7 of the ring (GAR synthetase step, forming glycinamide ribonucleotide, GAR)
• N10-formyl-tetrahydrofolate (first one-carbon transfer) - contributes carbon 8 (GAR transformylase, forming formylglycinamide ribonucleotide, FGAR)
• Glutamine (second amide nitrogen) - contributes nitrogen 3 (FGAM synthetase, forming formylglycinamidine ribonucleotide, FGAM)
• Ring closure by AIR synthetase, forming the 5-membered imidazole ring (aminoimidazole ribonucleotide, AIR)
• CO2 - contributes carbon 6 (AIR carboxylase, forming carboxyaminoimidazole ribonucleotide)
• Aspartate - contributes nitrogen 1 (SAICAR synthetase, forming SAICAR), and the carbon skeleton of aspartate is then removed as fumarate by adenylosuccinate lyase, leaving AICAR
• N10-formyl-tetrahydrofolate (second one-carbon transfer) - contributes carbon 2 (AICAR transformylase, forming FAICAR)
• Ring closure by IMP cyclohydrolase, which closes the six-membered purine ring and releases water, yielding IMP, the first complete purine nucleotide.

• IMP → adenylosuccinate (aspartate added, GTP-dependent) → AMP, via adenylosuccinate synthetase and adenylosuccinate lyase.
• IMP → xanthosine monophosphate (XMP) (oxidation by IMP dehydrogenase, NAD+-dependent) → GMP, via glutamine-dependent GMP synthetase.
• AMP and GMP are then phosphorylated (by kinases, and oxidative phosphorylation for ATP) to ADP/ATP and GDP/GTP respectively - Harper's Illustrated Biochemistry, Fig. 33-3, p. 351.

2. Regulation of Purine Biosynthesis

• Adenylosuccinate synthetase (IMP → AMP branch) is inhibited by AMP (end-product feedback).
• IMP dehydrogenase (IMP → GMP branch) is inhibited by GMP (end-product feedback).

3. How Adenosine Deaminase (ADA) Deficiency Causes SCID

1. ADA deficiency (autosomal recessive) blocks the normal breakdown of adenosine and deoxyadenosine.
2. These substrates accumulate and are converted by cellular kinases into their nucleotide forms, most importantly dATP (deoxyadenosine triphosphate).
3. Excess dATP is a potent allosteric inhibitor of ribonucleotide reductase, the enzyme that generates all four deoxyribonucleotides (dNTPs) needed for DNA synthesis.
4. With ribonucleotide reductase inhibited, cells cannot generate the deoxyribonucleotide pool needed for DNA replication, so they cannot synthesize DNA or divide.
5. Developing lymphocytes are exquisitely sensitive to this block because they are normally proliferating rapidly (clonal expansion, thymic/bone marrow maturation) and because lymphoid tissue has the highest baseline ADA activity, meaning ADA loss causes the greatest local buildup of toxic dATP/adenosine in exactly these cells.
6. The accumulated dATP and adenosine drive developmental arrest and apoptosis of T cells, B cells, and NK cells, rather than normal maturation - Biochemistry, 8th ed. Lippincott Illustrated Reviews, p. 848; Harper's Illustrated Biochemistry, p. 356.

Simple Explanation

1. How the Body Builds a Purine Ring (Simple Version)

• Glycine adds 3 atoms
• Glutamine (a second time) adds a nitrogen
• The ring closes into a 5-sided shape
• CO2 adds one carbon
• Aspartate adds a nitrogen
• Folic acid (vitamin B9) derivatives add 2 more carbons at two different steps
• The ring finally closes into its full 2-ring shape

• One path makes AMP (using energy from GTP)
• The other path makes GMP (using energy from ATP)

2. How the Body Controls Purine Production (Simple Version)

1. First brake (fuel supply): The enzyme that makes PRPP (the starting platform) is switched off when ADP and GDP (breakdown products) build up.
2. Main brake (the big one): The enzyme at the committed step (Step 2 above) is strongly blocked when both AMP and GMP (the final products) build up together. It's like a thermostat - too much finished product = shut down production.
3. Branch brakes:
   • Too much AMP blocks the enzyme that makes more AMP.
   • Too much GMP blocks the enzyme that makes more GMP.
4. Clever balancing trick: Making AMP requires GTP, and making GMP requires ATP. So if you have plenty of GTP, the body uses it to make more AMP; if you have plenty of ATP, it makes more GMP. This keeps the two pools (AMP-related and GMP-related) balanced with each other automatically.

3. Why Adenosine Deaminase (ADA) Deficiency Causes Severe Immunodeficiency (SCID)

1. Normally, an enzyme called ADA breaks down a molecule called adenosine (a leftover from purine recycling) into a harmless product.
2. If ADA is missing or broken (genetic defect), adenosine cannot be broken down and builds up.
3. Cells then convert this extra adenosine into dATP (a DNA-building-block look-alike), and dATP also builds up to abnormally high levels.
4. Too much dATP jams up a key enzyme called ribonucleotide reductase, which is needed to make the raw materials for new DNA.
5. Without that enzyme working, cells can't copy their DNA and therefore can't divide.
6. This hits immune cells (T cells and B cells) the hardest, because:
   • They normally need to divide rapidly to build the immune system
   • Immune cells naturally have the highest amount of ADA activity in the body, so when ADA is missing, the "poison" (dATP) builds up most in exactly these cells
7. As a result, T cells and B cells die off or fail to mature properly, leaving the child with almost no working immune system.
8. This condition is called Severe Combined Immunodeficiency (SCID) - "combined" because both T cells AND B cells are wiped out (unlike some other immune diseases that affect only one type).
9. Without treatment (bone marrow transplant, enzyme replacement shots, or gene therapy), babies with this condition usually die from infections before age 2, because they have almost no defense against germs.